Literature DB >> 15910232

Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients.

Yee Gyung Kwak1, Sang-Ho Choi, Eun Ju Choo, Jin-Won Chung, Jin-Yong Jeong, Nam Joong Kim, Jun-Hee Woo, Jiso Ryu, Yang Soo Kim.   

Abstract

The isolation of carbapenem-resistant Klebsiella pneumoniae (CRKP) has been increasingly reported. However, no study analyzing potential risk factors for the acquisition of CRKP has been published as of now. We therefore performed a case-control study to determine the risk factors for the acquisition of CRKP. CRKP was nosocomially isolated from 30 patients between January 1997 and August 2003. Control patients were randomly selected at a ratio of 4:1 from the same medical or surgical services from which patients were receiving care when isolation of CRKP occurred. Risk factors for CRKP were previous use of carbapenem (adjusted odds ratio [AOR], 28.68; 95% confidence interval [CI], 9.08-90.55) and cephalosporin (AOR, 4.10; 95% CI, 1.35-12.43). In contrast, previous use of fluoroquinolone was negatively associated with isolation of CRKP (AOR, 0.26; 95% CI 0.07-0.97); however, the possibility of selection bias cannot be ruled out. Our results suggest that the nosocomial isolation of CRKP is strongly favored by the selection pressure of carbapenem.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910232     DOI: 10.1089/mdr.2005.11.165

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  25 in total

1.  Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.

Authors:  Maristela Pinheiro Freire; Isabel C V S Oshiro; Ligia C Pierrotti; Patricia R Bonazzi; Larissa M de Oliveira; Alice T W Song; Carlos H Camargo; Inneke M van der Heijden; Flavia Rossi; Silvia F Costa; Luiz A C DʼAlbuquerque; Edson Abdala
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.

Authors:  S Shilo; M V Assous; T Lachish; P Kopuit; T Bdolah-Abram; A M Yinnon; Y Wiener-Well
Journal:  Infection       Date:  2012-12-28       Impact factor: 3.553

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.

Authors:  Paul P Cook; Michael Gooch; Shemra Rizzo
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

5.  Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.

Authors:  Federico Perez; Michael J Pultz; Andrea Endimiani; Robert A Bonomo; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

6.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.

Authors:  Yang Jiao; Yanghua Qin; Jiajun Liu; Qiang Li; Yuchao Dong; Yan Shang; Yi Huang; Rui Liu
Journal:  Pathog Glob Health       Date:  2015-02-24       Impact factor: 2.894

Review 7.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Authors:  Leanne B Gasink; Paul H Edelstein; Ebbing Lautenbach; Marie Synnestvedt; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

9.  Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.

Authors:  Christina Routsi; Maria Pratikaki; Evangelia Platsouka; Christina Sotiropoulou; Vasileios Papas; Theodoros Pitsiolis; Athanassios Tsakris; Serafeim Nanas; Charis Roussos
Journal:  Intensive Care Med       Date:  2013-04-20       Impact factor: 17.440

10.  Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.

Authors:  M P Freire; L C Pierrotti; H H C Filho; K Y Ibrahim; A S G K Magri; P R Bonazzi; L Hajar; M P E Diz; J Pereira; P M Hoff; E Abdala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-30       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.